BrainsWay Ltd. (BWAY)
BWAY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1505065/000117184326002568/0001171843-26-002568-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | BWAY on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | 2019 |
| SEC CIK | 0001505065 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | Israel |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $52.2M |
| Net income | $7.6M |
| Operating income | $4.3M |
| Net margin | 14.5% |
| Operating margin | 8.3% |
| Revenue growth | +27.3% |
| Cash | $67.7M |
| Total assets | $113.2M |
| P/E (computed) | 49.7× |
| P/S (computed) | 7.2× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-04-20 |
| Cash and burn | $67.7M cash; operating cash flow $4.4M a quarter. | Report 2025-12-31 |
| Shares outstanding | 39,165,806 (2025-12-31); 37,626,427 a year earlier; 33,053,323 three years earlier. 1y figure adjusted for split (2-for-1 overall); 3y figure adjusted for split (2-for-1 overall); the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Kost Forer Gabbay & Kasierer, Tel Aviv, Israel | PCAOB Form AP 2026-05-11 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | $52.2M | $7.6M | $17.5M | $67.7M | No debt tags | $52.2M | 20-F 2026-04-20 |
| FY 2024 2024-12-31 | $41.0M | $2.9M | $10.3M | $69.3M | No debt tags | $41.0M | 20-F 2025-04-22 |
| FY 2023 2023-12-31 | $31.8M | -$4.2M | $1.3M | $10.5M | No debt tags | $31.8M | 20-F 2025-04-22 |
| FY 2022 2022-12-31 | $27.2M | -$13.3M | -$9.8M | $47.6M | No debt tags | $27.2M | 20-F 2025-04-22 |
| FY 2021 2021-12-31 | $29.7M | -$6.5M | $884K | $16.9M | No debt tags | $29.7M | 20-F 2024-03-28 |
| FY 2020 2020-12-31 | $22.1M | -$5.4M | -$1.4M | $17.0M | No debt tags | $22.1M | 20-F 2023-03-27 |
| FY 2019 2019-12-31 | $23.1M | -$10.3M | -$7.2M | $21.7M | No debt tags | $23.1M | 20-F 2022-04-12 |
| FY 2018 2018-12-31 | $16.4M | -$6.5M | -$3.8M | $9.0M | $2.8M | $16.4M | 20-F 2021-04-19 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2025-05-01 |
| Latest annual report FORM 20-F | 20-F | 2026-04-20 |
| Latest quarterly / interim FORM 6-K | 6-K | 2026-11-10 |
Source: SEC EDGAR submissions feed, 283 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -9.3% |
| 1 month | -15.2% |
| 3 months | -38.6% |
| Year to date | +6.3% |
| 1 year | +26.3% |
| From 52-week high | -41.1% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CERS | Cerus Corporation | $1.86 | -6.30% | $375.6M |
| EMBC | Embecta Corp. | $6.25 | -3.25% | $354.1M |
| SI | Shoulder Innovations Inc. | $20.45 | -1.16% | $427.9M |
| MOBI | Mobia Medical Inc. | $13.15 | -0.15% | $438.3M |
| MDXG | MiMedx Group Inc | $3.18 | -0.93% | $464.0M |
| CARL | Carlsmed Inc. | $17.35 | +1.34% | $475.5M |
| RCEL | Avita Medical Inc. | $15.22 | -2.62% | $478.2M |
| INFU | InfuSystems Holdings Inc. | $14.79 | +0.48% | $296.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier